Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30

$1.94+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $12.29MP/E –Yield –

Propanc Biopharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2014 it was $0.

Period	Period end	Value	Change
FY2014	Jun 30, 2014	$0	–

See a number that looks wrong?